SuperworthMedicus Pharma price to book ratio MDCX
Market value divided by the book value of the company's net assets, since 2025.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 12.8×
- Aug 2026
- Peer median
- 1.0×
Medicus Pharma's price to book ratio is not a meaningful number today: shareholders' equity was zero, negative or not reported, so price to book does not exist.
It was last meaningful in Aug 2026, at 12.8×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 12.8× | 11.8× | 19.6× |
| 2025 | 12.1× | 10.3× | 45.8× |
Against its peers
Companies in Healthcare nearest Medicus Pharma's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| MDCXMedicus Pharma | n/m |
| OXBROXBRIDGE RE HOLDINGS | 1.2× |
| EDUCEducational Development | 0.2× |
| GTIMGood Times Restaurants | 0.4× |
| MDRRMedalist Diversified | 0.6× |
| BCGBinah Capital | 0.9× |
| VIPVulcan Infrastructure & Power | n/m |
| MXCMexco Energy | 1.0× |
| CKXCKX Lands | 1.0× |
| MSGMMotorsport Games | 5.8× |
| ATCHAtlasClear | 1.1× |
| Peer median | 1.0× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Medicus Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.